Carol Deby
University of Liège
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carol Deby.
Cellular and Molecular Life Sciences | 1989
Joël Pincemail; M. Dupuis; C. Nasr; Pol Hans; M. Haag-Berrurier; R. Anton; Carol Deby
Ginkgo biloba extract is known to be efficient in diseases associated with free radical generation. The purpose of this work was to study, under in vitro conditions, the action ofGinkgo biloba extract (Gbe) against superoxide anion (
Journal of Veterinary Diagnostic Investigation | 2005
Thierry Franck; Sigrid Grulke; G. Deby-Dupont; Carol Deby; Hania Duvivier; Fabrice Péters; Didier Serteyn
Journal of Veterinary Diagnostic Investigation | 2006
Thierry Franck; Stephan Kohnen; G. Deby-Dupont; Sigrid Grulke; Carol Deby; Didier Serteyn
O_{2^{\bar .} }
Cellular and Molecular Life Sciences | 1996
M. Mathy-Hartert; G. Deby-Dupont; P. Melin; Maurice Lamy; Carol Deby
Coronary Artery Disease | 2005
Olivier Gach; Christian Biemar; Monique Nys; G. Deby-Dupont; Jean-Paul Chapelle; Carol Deby; Maurice Lamy; Luc Pierard; Victor Legrand
), which is directly or indirectly implicated in cell damage. Gbe appears to have both an
Bioelectrochemistry and Bioenergetics | 1987
Joël Pincemail; Carol Deby; Anne Dethier; Yanick Bertrand; Michel Lismonde; Maurice Lamy
Biochimica et Biophysica Acta | 1998
G. Deby-Dupont; Carol Deby; Ange Mouithys-Mickalad; Maryse Hoebeke; M. Mathy-Hartert; Luc Jadoul; Alain Vandenberghe; Maurice Lamy
O_{2^{\bar .} }
Redox Report | 2004
Ange Mouithys-Mickalad; Juan Mareque-Faez; Léon Chistiaens; Stephan Kohnen; Carol Deby; Maryse Hoebeke; Maurice Lamy; G. Deby-Dupont
European Journal of Clinical Microbiology & Infectious Diseases | 1998
R. Carreer; G. Deby-Dupont; Carol Deby; L. Jadoul; Marianne Mathy
scavenging effect and also a superoxide dismutase activity. Its antiradical effect was demonstrated by low temperature electron spin resonance and in a non-enzymatic system (phenazine methosulfate-NADH), and its enzymatic activity was shown by polarographic determination.
Redox Report | 2002
Ange Mouithys-Mickalad; M. Mathy-Hartert; Guanadu Du; Francis Sluse; Carol Deby; Maurice Lamy; G. Deby-Dupont
Equine inflammatory disease is accompanied by a neutrophil activation resulting in the release of granulocytic enzyme myeloperoxidase (MPO). To measure MPO in horse plasma as marker of neutrophil activation, the authors purified equine neutrophil MPO and developed a specific enzyme immunoassay using 2 specific polyclonal antibodies obtained from rabbit (primary antibody) and guinea pig (secondary antibody). The sandwich complex “primary antibody-MPO-secondary antibody” was detected using a goat anti-guinea pig immunoglobulin antibody conjugated to alkaline phosphatase. The enzyme-linked immunosorbent assay (ELISA) showed good precision and accuracy, with intra- and interassay coefficients of variation below 10% for MPO concentrations ranging from 0.78 to 50 ng/ml. A stable plasma MPO value, unaffected by time elapsed between blood collection and centrifugation, was obtained with plasma from EDTA anticoagulated blood. The mean MPO value measured in 38 healthy horses was 181.80 ± 64.74 ng/ml. In 20 horses suffering from obstruction of the large or small intestine, MPO concentrations measured at the time of arrival at the intensive care unit were significantly higher than mean normal value, ranging from 477.88 to 2,748.13 ng/ml. Work is in progress to apply this MPO ELISA technique to other biological fluids and other equine diseases.